Combo Therapy May Prevent Cancer's Return After Liver Surgery

MONDAY, April 24, 2023 -- A two-drug combination therapy can enhance survival odds for people with early-stage liver cancer through targeted attacks on tumor cells, a new clinical trial shows.
The combo -- atezolizumab (Tecentriq) and bevacizumab...